Article
Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.
Journal of clinical lipidology - 1 Jan 2000
Mendoza Saulo, Trenchevska Olgica, King Sarah M, Nelson Randall W, Nedelkov Dobrin, Krauss Ronald M, Yassine Hussein N
Abstract excerpt
BACKGROUND: The presence of small dense low-density lipoprotein (LDL) is associated with obesity, type II diabetes, and an increased risk for cardiovascular disease. Apolipoprotein C-III (apoC-III) is involved in the formation of small dense LDL, but the exact mechanisms are still not well defined. ApoC-III is a glycosylated apolipoprotein, with 3 major glycoforms: apoC-III0, apoC-III1, and apoC-III2 that contain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
